Develops and commercializes treatments for central nervous system disorders.
| Title |
|---|
| Medical Director, Clinical Development - CNS Full Time · 3+ YOE Paramus, New Jersey, United States · Onsite |
| Neuroscience Account Manager - Columbus, OH Full Time · 2+ YOE Columbus, Ohio, United States · Hybrid |
| Executive Director, Marketing Full Time · 15+ YOE Paramus, New Jersey, United States · Onsite |
| Medical Science Liaison - Southeast Full Time Tampa, Florida, United States · Remote |
| Marketing Development Manager - Central Full Time · 10+ YOE Kentucky or Indiana or Illinois or Missouri or Iowa or Nebraska or Kansas · Hybrid |
| Associate Director GCP/PVG Quality Assurance Full Time · 10+ YOE Paramus, New Jersey, United States · Onsite |
| Intern - AI Engineering Internship Paramus, New Jersey, United States · Onsite |
| Corporate Account Director (Ascent, Express Scripts) Full Time · 7+ YOE United States · Onsite |
| Senior Manager, Commercial IT Data Engineer Full Time · $120K-$170K · 3+ YOE Paramus, New Jersey, United States · Onsite |
| Senior Manager, Commercial Learning & Development Full Time · 5+ YOE Paramus, New Jersey, United States · Onsite |
| AI Engineer, Business Operations Full Time · 3+ YOE Paramus, New Jersey, United States · Onsite |
| Senior Data Engineer, Business Operations Full Time · 5+ YOE Paramus, New Jersey, United States · Onsite |
| Senior Director, Clinical Development - Oncology - SK Life Science Labs Full Time · 10+ YOE United States · Onsite |
| Activities | Drug discoveryPharmaceutical manufacturingClinical researchBiotechnology researchCommercializing prescription drugs |
| Headquarters | US |
| Industries | PharmaceuticalsBiotechnology |
| Name | SK Life Science |
| Employees | 363 |
| Type | Private |
| Parent Company | SK Biopharmaceuticals |
| Subsidiaries | SK Life Science LabsOncopia Therapeutics |
| Tagline | Develops and commercializes treatments for central nervous system disorders. |
| Founded | 1,993 |
| Website | sklifescienceinc.com |
| Latest Funding Round | Corporate Round |
| Latest Funding Year | 2,026 |
| Latest Funding Amount | 36,000,000 |
| Latest Investors | SK Biopharmaceuticals |